Global Pharmacovigilance Market Size, Forecasts, And Opportunities – Includes Pharmacovigilance Market Share
Learn about the global pharmacovigilance market through The Business Research Company, which provides information on pharmacovigilance market size, pharmacovigilance market drivers and restraints, pharmacovigilance market players, the COVID-19 impact on the pharmacovigilance market, and more.
The global pharmacovigilance market is expected to grow from $5.71 billion in 2021 to $6.64 billion in 2022 at a compound annual growth rate (CAGR) of 16.2%. The global pharmacovigilance market is expected to reach $10.57 billion in 2026 at a CAGR of 12.3%.
The growing incidences of adverse drug reactions are expected to propel the growth of the pharmacovigilance market going forward.
Request A Sample For The Global Pharmacovigilance Market Report:
The pharmacovigilance market consists of sales of pharmacovigilance services by entities (organizations, sole traders, and partnerships) that collect, assess, and distribute drug safety and efficiency data. Pharmacovigilance is the science and practice of monitoring approved pharmaceuticals and experimental products prior to their approval for use in order to discover, evaluate, assess, and avoid adverse drug and vaccination effects and problems.
Global Pharmacovigilance Market Segments Include:
By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
By Service Provider: In-House, Contract Outsourcing
By Process Flow: Case Data Management, Signal Detection, Risk Management System
By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
By End User: Hospitals, Pharmaceutical Companies, Other End Users
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the pharmacovigilance market in 2021.
Technological advancements have emerged as a key trend gaining popularity in the pharmacovigilance market. Many companies operating in the pharmacovigilance sector are adopting advanced technological solutions such as Artificial intelligence (AI) to reduce cycle time, enriched quality and accuracy, scalable and futuristic solutions, improved productivity, and better compliance.
TBRC’s pharmacovigilance market report covers:
Major Market Players: Accenture, Cognizant, Labcorp Drug Development, IQVIA, IQVIA, Parexel International Corporation, BioClinica Inc., Clinquest Inc., ITClinical, TAKE Solutions Limited, United BioSource LLC, Wipro Limited, Bristol-Myers Squibb Company, Linical Americas, iMEDGlobal, Boehringer Ingelheim International GmbH, Novartis AG, Ecron Acunova Limited, and Sanofi.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)
The Pharmacovigilance Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides pharmacovigilance market overviews, analyzes and forecasts market size, share, pharmacovigilance market players, pharmacovigilance market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s pharmacovigilance market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports From The Business Research Company:
Pharma Microbiology Testing Kits Global Market Report 2022
Pharmaceutical API Manufacturing Global Market Report 2022
Pharmaceutical Excipients Global Market Report 2022
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: